K Hiramatsu - The Lancet infectious diseases, 2001 - thelancet.com
Vancomycin has been the most reliable therapeutic agent against infections caused by meticillin-resistant Staphylococcus aureus (MRSA). However, in 1996 the first MRSA to …
DJ Diekema, MA Pfaller, FJ Schmitz… - Clinical infectious …, 2001 - academic.oup.com
Abstract Between January 1997 and December 1999, bloodstream isolates from 15,439 patients infected with Staphylococcus aureus and 6350 patients infected with coagulase …
M Wootton, RA Howe, R Hillman… - Journal of …, 2001 - academic.oup.com
One hundred methicillin-resistant Staphylococcus aureus (MRSA) strains, isolated between 1983 and 1999, were tested alongside the vancomycin hetero-resistant S. aureus (hVRSA) …
Although infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility (SA-RVS) have been reported from a number of countries …
Strains of Staphylococcus aureus with reduced susceptibility to glycopeptides have been reported from Japan, the United States, Europe, and the Far East. Although isolates with …
We assessed all episodes of methicillin-resistant Staphy lococcus aureus (MRSA) bacteremia at our hospital during a 12-month period (n= 53) and compared those due to …
C Liu, HF Chambers - Antimicrobial agents and chemotherapy, 2003 - Am Soc Microbiol
The first report of Staphylococcus aureus with intermediate-level resistance to vancomycin (VISA) was from Japan in 1997 (20), raising the threat of incurable staphylococcal infections …
AC Fluit, CLC Wielders, J Verhoef… - Journal of clinical …, 2001 - Am Soc Microbiol
ABSTRACT A total of 3,051 methicillin-susceptible Staphylococcus aureus (MSSA) isolates and methicillin-resistant S. aureus (MRSA) isolates in Europe were compared. MRSA …
S Zhang, X Sun, W Chang, Y Dai, X Ma - PloS one, 2015 - journals.plos.org
Background Vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA (hVISA) are associated with vancomycin treatment failure, and are becoming an …